The publication of results from a recent study in the New England Journal of Medicine using...
The publication of results from a recent study in the New England Journal of Medicine using Allergan's (AGN +0.5%) Botox as a treatment for overactive bladder in women looks to be a positive. Results showed that a single injection of Botox into a woman’s bladder reduces urinary incontinence as effectively as daily drugs and is actually better at resolving the problem. This opens up a new market for the drug as a first line of defense for women who struggle with frequent urinary leakage, and if approved, could generate as much as $216M in sales by 2015.
From other sites
at CNBC.com (Feb 18, 2015)
at CNBC.com (Feb 10, 2015)
at CNBC.com (Jan 26, 2015)
at CNBC.com (Jan 14, 2015)
at CNBC.com (Jan 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs